PFE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Pfizer Inc's quarterly accounts payable increased from Mar. 2015 ($5,347 Mil) to Jun. 2015 ($7,359 Mil) and increased from Jun. 2015 ($7,359 Mil) to Sep. 2015 ($8,355 Mil).
Pfizer Inc's annual accounts payable declined from Dec. 2012 ($7,508 Mil) to Dec. 2013 ($7,367 Mil) but then increased from Dec. 2013 ($7,367 Mil) to Dec. 2014 ($7,466 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Pfizer Inc Annual Data
Pfizer Inc Quarterly Data